293 related articles for article (PubMed ID: 29541073)
1. The Effect of TNF-α on Regulatory T Cell Function in Graft-versus-Host Disease.
Mancusi A; Piccinelli S; Velardi A; Pierini A
Front Immunol; 2018; 9():356. PubMed ID: 29541073
[TBL] [Abstract][Full Text] [Related]
2. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.
Pierini A; Strober W; Moffett C; Baker J; Nishikii H; Alvarez M; Pan Y; Schneidawind D; Meyer E; Negrin RS
Blood; 2016 Aug; 128(6):866-71. PubMed ID: 27365424
[TBL] [Abstract][Full Text] [Related]
3. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
[TBL] [Abstract][Full Text] [Related]
4. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
Nguyen VH; Zeiser R; Negrin RS
Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
[TBL] [Abstract][Full Text] [Related]
5. Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.
Stamou P; Marioli D; Patmanidi AL; Sgourou A; Vittoraki A; Theofani E; Pierides C; Taraviras S; Costeas PA; Spyridonidis A
Cytotherapy; 2017 Apr; 19(4):521-530. PubMed ID: 28162915
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function.
Skartsis N; Peng Y; Ferreira LMR; Nguyen V; Ronin E; Muller YD; Vincenti F; Tang Q
Front Immunol; 2021; 12():783282. PubMed ID: 35003100
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic use of regulatory T cells for graft-versus-host disease.
Elias S; Rudensky AY
Br J Haematol; 2019 Oct; 187(1):25-38. PubMed ID: 31418827
[TBL] [Abstract][Full Text] [Related]
8. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
[TBL] [Abstract][Full Text] [Related]
9. Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.
Haase D; Starke M; Puan KJ; Lai TS; Rotzschke O
Immunol Res; 2012 Sep; 53(1-3):200-12. PubMed ID: 22418725
[TBL] [Abstract][Full Text] [Related]
10. CD4
Mancusi A; Piccinelli S; Velardi A; Pierini A
Front Immunol; 2019; 10():2901. PubMed ID: 31921162
[TBL] [Abstract][Full Text] [Related]
11. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
13. Large-scale Isolation of Highly Pure "Untouched" Regulatory T Cells in a GMP Environment for Adoptive Cell Therapy.
Haase D; Puan KJ; Starke M; Lai TS; Soh MY; Karunanithi I; San Luis B; Poh TY; Yusof N; Yeap CH; Phang CY; Chye WS; Chan M; Koh MB; Goh YT; Bertin-Maghit S; Nardin A; Ho LP; Rotzschke O
J Immunother; 2015; 38(6):250-8. PubMed ID: 26049548
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
Theil A; Tuve S; Oelschlägel U; Maiwald A; Döhler D; Oßmann D; Zenkel A; Wilhelm C; Middeke JM; Shayegi N; Trautmann-Grill K; von Bonin M; Platzbecker U; Ehninger G; Bonifacio E; Bornhäuser M
Cytotherapy; 2015 Apr; 17(4):473-86. PubMed ID: 25573333
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of induced and natural FoxP3(+) regulatory T cells for the treatment of Graft-versus-host disease.
Prinz I; Koenecke C
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):183-90. PubMed ID: 22476537
[TBL] [Abstract][Full Text] [Related]
16. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
[TBL] [Abstract][Full Text] [Related]
17. The role of regulatory T cells in graft-versus-host disease management.
Whangbo JS; Antin JH; Koreth J
Expert Rev Hematol; 2020 Feb; 13(2):141-154. PubMed ID: 31874061
[No Abstract] [Full Text] [Related]
18. Regulatory T Cells in GVHD Therapy.
Guo WW; Su XH; Wang MY; Han MZ; Feng XM; Jiang EL
Front Immunol; 2021; 12():697854. PubMed ID: 34220860
[TBL] [Abstract][Full Text] [Related]
19. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.
Albert MH; Liu Y; Anasetti C; Yu XZ
Eur J Immunol; 2005 Sep; 35(9):2598-607. PubMed ID: 16078276
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]